miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway Ting JiangJinfeng ChenYanke Chen Review Article 17 July 2023 Pages: 691 - 702
An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers Reiko FukuiTakahiro WatanabeYasuo Miyoshi Original Article Open access 28 April 2023 Pages: 703 - 713
Role of circ-FOXO3 and miR-23a in radiosensitivity of breast cancer Elahe AbdollahiHossein MozdaraniBehrooz Z. Alizadeh Original Article 24 May 2023 Pages: 714 - 726
Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells Takako SakamotoKeiji TanimotoSahoko Ichihara Original Article 11 May 2023 Pages: 727 - 738
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population Yuri TakeharaNaoko MatsudaNaoki Hayashi Original Article 01 June 2023 Pages: 739 - 747
Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration Freeha KhalidKiyoshi TakagiTakashi Suzuki Original Article 13 May 2023 Pages: 748 - 757
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro Lili LinKristina PfenderAnna Hester Original Article Open access 18 May 2023 Pages: 758 - 771
What affects women’s decision-making on breast reconstruction after mastectomy for breast cancer? Sara van BekkumMarloes E. ClarijsMarian B. E. Menke-Pluijmers Original Article 12 June 2023 Pages: 772 - 784
Association between chronic pain and quality of life in long-term breast cancer survivors: a prospective analysis Michelle YinKai GuXiao-Ou Shu Original Article 17 June 2023 Pages: 785 - 795
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia Michael RainoneCarolyn E. BehrendtVinod Pullarkat Original Article Open access 16 June 2023 Pages: 796 - 801
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study M. GhilliM. D. MarinielloM. Roncella Original Article Open access 26 June 2023 Pages: 802 - 809
Association of psychological distress with arm morbidity symptoms in breast cancer survivors: outcomes from the use of PHQ-9 and GAD-7 questionnaires Khairunnisa’ Md YusofSherina Mohd SidikRozita Rosli Original Article 12 June 2023 Pages: 810 - 819
Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives Sumito SaekiTsuguo IwataniCollaborative Study Group of Scientific Research of the Japanese Breast Cancer Society Original Article Open access 13 June 2023 Pages: 820 - 830
Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives Sumito SaekiTsuguo IwataniCollaborative Study Group of Scientific Research of the Japanese Breast Cancer Society Correction Open access 03 July 2023 Pages: 831 - 831
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer Raviprasad KuthethurMaria Sona JeromeSanjiban Chakrabarty Original Article Open access 21 June 2023 Pages: 832 - 844
The transverse myocutaneous gracilis flap (TMG) for breast reconstruction: ipsi vs. contralateral harvest—aesthetic outcome and refinement procedures Felix H. VollbachClara NeussDimitra Kotsougiani-Fischer Original Article 01 July 2023 Pages: 845 - 855
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer Yoko SuzukiTakayuki IwamotoShinichi Toyooka Original Article 08 July 2023 Pages: 856 - 868
